Quinazoline derivatives as potential anticancer agents: a patent review (2007 – 2010)

Eguchi S, Eguchi S. Quinazoline Alkaloids and Related Chemistry Bioactive Heterocycles I. Springer Berlin; Heidelberg: 2006. p. 113-56

10.1021/bi00098a028

Skelton LA, 1999, Br J Cancer, 79, 1692, 10.1038/sj.bjc.6690270

Scanlon KJ, 1979, Mol Pharmacol, 16, 261

Oatis JE, 1977, J Med Chem, 20, 1393, 10.1021/jm00221a008

Davoll J, 1970, J Chem Soc, 8, 997

Martin GJ, 1947, J Biol Chem, 167, 737, 10.1016/S0021-9258(17)30957-2

Cavalli A, 2010, FEMS Immunol Med Microbiol, 58, 51, 10.1111/j.1574-695X.2009.00615.x

10.1016/j.ijantimicag.2010.03.027

Elslager EF, 1978, J Med Chem, 21, 639, 10.1021/jm00205a009

Elslager EF, 1978, J Med Chem, 21, 1059, 10.1021/jm00208a010

Rohini R, 2009, Eur J Med Chem, 44, 3330, 10.1016/j.ejmech.2009.03.022

Desai NC, 1998, Indian J Exp Biol, 36, 1280

Chao Q, 1999, J Med Chem, 42, 3860, 10.1021/jm9805900

el-Bendary ER, 1996, Boll Chim Farm, 135, 617

Jindal DP, 2002, Eur J Med Chem, 37, 419, 10.1016/S0223-5234(02)01345-4

Combs DW, 1990, Drug Des Deliv, 6, 241

Chen Z, 2009, Bioorg Med Chem, 17, 2351, 10.1016/j.bmc.2009.02.015

Tseng CJ, 1995, Proc Natl Sci Counc Repub China B, 19, 159

Uckun FM, 2001, Curr Cancer Drug Targets, 1, 59, 10.2174/1568009013334287

10.4161/cbt.4.10.1995

Ghosh S, 1999, Anti Cancer Drug Des, 14, 403

Cunningham D, 1996, Ann Oncol, 7, 179, 10.1093/oxfordjournals.annonc.a010546

Chilin A, 2010, J Med Chem, 53, 1862, 10.1021/jm901338g

Marzaro G, 2010, Tetrahedron, 66, 962, 10.1016/j.tet.2009.11.091

Wang C, 2010, J Org Chem, 75, 7936, 10.1021/jo101685d

Yang X, 2010, Synlett, 4, 101

Ferrini S, 2007, Org Lett, 9, 69, 10.1021/ol062540s

Moulder SL, 2001, Cancer Res, 61, 8887

Hanks SK, 1995, Faseb J, 9, 576, 10.1096/fasebj.9.8.7768349

Manning G, 2002, Science, 298, 1912, 10.1126/science.1075762

Liao JJ, 2007, J Med Chem, 50, 409, 10.1021/jm0608107

Capra M, 2006, Cancer Res, 66, 8147, 10.1158/0008-5472.CAN-05-3489

Tsatsanis C, 2000, Int J Mol Med, 5, 583

Dietrich J, 2010, Bioorg Med Chem, 18, 292, 10.1016/j.bmc.2009.10.055

Davies H, 2002, Nature, 417, 949, 10.1038/nature00766

Hennessy BT, 2005, Nat Rev Drug Discov, 4, 988, 10.1038/nrd1902

Vivanco I, 2002, Nat Rev Cancer, 2, 489, 10.1038/nrc839

Converso A, 2009, Bioorg Med Chem Lett, 19, 1240, 10.1016/j.bmcl.2008.12.076

Harrington EA, 2004, Nat Med, 10, 262, 10.1038/nm1003

Sardon T, 2009, ChemBioChem, 10, 464, 10.1002/cbic.200800600

Girdler F, 2006, J Cell Sci, 119, 3664, 10.1242/jcs.03145

10.1186/1471-2407-11-254

Mortlock AA, 2007, J Med Chem, 50, 2213, 10.1021/jm061335f

10.1016/j.bcp.2011.02.010

Wilkinson RW, 2007, Clin Cancer Res, 13, 3682, 10.1158/1078-0432.CCR-06-2979

Walsby E, 2008, Haematologica, 93, 662, 10.3324/haematol.12148

Azzariti A, 2011, Br J Cancer, 104, 769, 10.1038/bjc.2011.21

10.1158/1535-7163.MCT-06-0004

10.1016/0092-8674(86)90595-7

Fischer V, 2005, Mini Rev Med Chem, 5, 183, 10.2174/1389557053402756

Strebhardt K, 2010, Nat Rev Drug Discov, 9, 643, 10.1038/nrd3184

Yuan J, 1997, Am J Pathol, 150, 1165

Ando K, 2004, J Biol Chem, 279, 25549, 10.1074/jbc.M314182200

Beria I, 2011, Bioorg Med Chem Lett, 21, 2969, 10.1016/j.bmcl.2011.03.054

Beria I, 2010, Bioorg Med Chem Lett, 20, 6489, 10.1016/j.bmcl.2010.09.060

Beria I, 2010, J Med Chem, 53, 3532, 10.1021/jm901713n

Brasca MG, 2009, J Med Chem, 52, 5152, 10.1021/jm9006559

Degrassi A, 2010, Mol Cancer Ther, 9, 673, 10.1158/1535-7163.MCT-09-0726

Caporali S, 2010, Pharmacol Res, 61, 437, 10.1016/j.phrs.2009.12.009

Krause DS, 2005, N Engl J Med, 353, 172, 10.1056/NEJMra044389

Paul MK, 2004, Int J Med Sci, 1, 101, 10.7150/ijms.1.101

Kanda S, 2007, Int J Mol Med, 20, 113

Brunelleschi S, 2002, Curr Pharm Des, 8, 1959, 10.2174/1381612023393530

Petrelli A, 2008, Curr Med Chem, 15, 422, 10.2174/092986708783503212

van der Geer P, 1994, Annu Rev Cell Biol, 10, 251, 10.1146/annurev.cb.10.110194.001343

10.1042/BC20080020

10.1038/sj.onc.1211016

Hilbig A, 2008, Recent Res Cancer, 177, 179, 10.1007/978-3-540-71279-4_19

Hiscox S, 2007, Clin Exp Metastasis, 24, 157, 10.1007/s10585-007-9065-y

Dayam R, 2007, Expert Opin Ther Patents, 17, 83, 10.1517/13543776.17.1.83

Herbst RS, 2002, Semin Oncol, 29, 27, 10.1053/sonc.2002.31525

Nishio M, 2006, Anticancer Res, 26, 3761

Maheswaran S, 2008, N Engl J Med, 359, 366, 10.1056/NEJMoa0800668

Michalczyk A, 2008, Bioorg Med Chem, 16, 3482, 10.1016/j.bmc.2008.02.053

10.1016/S0093-7754(01)90285-4

Rixe O, 2009, Cancer Chemother Pharm, 64, 1139, 10.1007/s00280-009-0975-z

Sachdev JC, 2012, Clin Breast Cancer, 12, 19, 10.1016/j.clbc.2011.07.001

Ou SH, 2012, Crit Rev Oncol Hematol

Gonzales AJ, 2008, Mol Cancer Ther, 7, 1880, 10.1158/1535-7163.MCT-07-2232

Cha MY, 2009, J Med Chem, 52, 6880, 10.1021/jm901146p

Li D, 2008, Oncogene, 27, 4702, 10.1038/onc.2008.109

10.1038/bjc.2011.396

Eskens FA, 2008, Br J Cancer, 98, 80, 10.1038/sj.bjc.6604108

Ballou LM, 2008, J Chem Biol, 1, 27, 10.1007/s12154-008-0003-5

10.1073/pnas.0808930106

Regales L, 2009, J Clin Invest, 119, 3000

Barlaam B, 2008, Bioorg Med Chem Lett, 18, 1799, 10.1016/j.bmcl.2008.02.035

Pennell NA, 2009, Oncologist, 14, 399, 10.1634/theoncologist.2008-0276

Alferez D, 2008, Mol Cancer Ther, 7, 590, 10.1158/1535-7163.MCT-07-0433

10.1016/j.canlet.2007.02.006

Scott EN, 2007, Expert Opin Investig Drugs, 16, 367, 10.1517/13543784.16.3.367

Sathornsumetee S, 2006, Drugs Today, 42, 657, 10.1358/dot.2006.42.10.1025318

DeVita VT, 1973, N Engl J Med, 288, 998, 10.1056/NEJM197305102881905

Chefrour M, 2011, Fundam Clin Pharmacol

10.1200/JCO.2009.26.9571

Chu E, 2011, Oncology, 25, 538

10.1200/JCO.2008.21.3223

Ushiyama S, 2008, Eur J Pharmacol, 578, 76, 10.1016/j.ejphar.2007.08.034

Ali S, 2005, Mol Cancer Ther, 4, 1943, 10.1158/1535-7163.MCT-05-0065

Kao J, 2009, Curr Cancer Drug Targets, 9, 931, 10.2174/156800909790192437

Koki AT, 1999, Expert Opin Investig Drugs, 8, 1623, 10.1517/13543784.8.10.1623

Buzdar AU, 2001, Br J Cancer, 85, 6

Hickinson DM, 2010, Clin Cancer Res, 16, 1159, 10.1158/1078-0432.CCR-09-2353

Thiagalingam S, 2003, Ann NY Acad Sci, 983, 84, 10.1111/j.1749-6632.2003.tb05964.x

Dokmanovic M, 2007, Mol Cancer Res, 5, 981, 10.1158/1541-7786.MCR-07-0324

Cai X, 2010, J Med Chem, 53, 2000, 10.1021/jm901453q

Miller TA, 2003, J Med Chem, 46, 5097, 10.1021/jm0303094

10.1158/0008-5472.CAN-09-3360

Fridman JS, 2003, Oncogene, 22, 9030, 10.1038/sj.onc.1207116

Vogelstein B, 2000, Nature, 408, 307, 10.1038/35042675

Demma M, 2010, J Biol Chem, 285, 10198, 10.1074/jbc.M109.083469

Theti DS, 2003, Cancer Res, 63, 3612

Gibbs DD, 2005, Cancer Res, 65, 11721, 10.1158/0008-5472.CAN-05-2034

Henderson EA, 2006, Bioorg Med Chem, 14, 5020, 10.1016/j.bmc.2006.03.001

Smith JC, 1994, Cell, 76, 193, 10.1016/0092-8674(94)90325-5

Rubin LL, 2006, Nat Rev Drug Discov, 5, 1026, 10.1038/nrd2086

Nelson WJ, 2004, Science, 303, 1483, 10.1126/science.1094291

Kinzler KW, 1996, Cell, 87, 159, 10.1016/S0092-8674(00)81333-1

Chen Z, 2009, Bioorg Med Chem Lett, 19, 4980, 10.1016/j.bmcl.2009.07.070

Dehnhardt CM, 2010, J Med Chem, 53, 897, 10.1021/jm901370m

Neumann S, 2009, Proc Natl Acad Sci USA, 106, 12471, 10.1073/pnas.0904506106

Srivastava V, 2010, Eur J Med Chem, 45, 1560, 10.1016/j.ejmech.2009.12.065

10.1016/j.ejmech.2011.02.072

Tanrikulu Y, 2008, Nat Rev Drug Discov, 7, 667, 10.1038/nrd2615